Healthcare provider profile · identity verified

Andrew G Macri, D.O.

Internal Medicine · PALOS HILLS, IL · NPI 1720092463

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	939	266
Amlodipine Besylate	Amlodipine Besylate	592	172
Metoprolol Succinate	Metoprolol Succinate	455	126
Lisinopril	Lisinopril	401	112
Losartan Potassium	Losartan Potassium	324	97
Hydrochlorothiazide	Hydrochlorothiazide	304	87
Levothyroxine Sodium	Levothyroxine Sodium	289	79
Metformin Hcl	Metformin Hcl	280	78
Alprazolam	Alprazolam	260	59
Gabapentin	Gabapentin	258	61
Eliquis	Apixaban	257	48
Tamsulosin Hcl	Tamsulosin Hcl	257	76
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	253	50
Glimepiride	Glimepiride	249	67
Metoprolol Tartrate	Metoprolol Tartrate	239	66
Omeprazole	Omeprazole	219	63
Pantoprazole Sodium	Pantoprazole Sodium	195	61
Furosemide	Furosemide	180	69
Allopurinol	Allopurinol	168	47
Tramadol Hcl	Tramadol Hcl	164	56
Simvastatin	Simvastatin	160	45
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	146	34
Albuterol Sulfate Hfa	Albuterol Sulfate	142	37
Escitalopram Oxalate	Escitalopram Oxalate	138	43
Rosuvastatin Calcium	Rosuvastatin Calcium	131	44
Sertraline Hcl	Sertraline Hcl	124	43
Carvedilol	Carvedilol	116	29
Clopidogrel	Clopidogrel Bisulfate	112	33
Ozempic	Semaglutide	112	21
Famotidine	Famotidine	102	35
Jardiance	Empagliflozin	102	39
Alendronate Sodium	Alendronate Sodium	92	29
Meloxicam	Meloxicam	84	27
Prednisone	Prednisone	84	55
Triamcinolone Acetonide	Triamcinolone Acetonide	79	39
Potassium Chloride	Potassium Chloride	78	24
Donepezil Hcl	Donepezil Hcl	74	25
Lorazepam	Lorazepam	74	11
Trazodone Hcl	Trazodone Hcl	68	16
Duloxetine Hcl	Duloxetine Hcl	66	20
Hydralazine Hcl	Hydralazine Hcl	66	22
Lovastatin	Lovastatin	66	18
Zolpidem Tartrate	Zolpidem Tartrate	66	13
Warfarin Sodium	Warfarin Sodium	63	17
Fenofibrate	Fenofibrate Nanocrystallized	58	14
Finasteride	Finasteride	55	18
Fluticasone Propionate	Fluticasone Propionate	54	23
Doxycycline Hyclate	Doxycycline Hyclate	51	45
Hydroxyzine Hcl	Hydroxyzine Hcl	50	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	14
Bupropion Xl	Bupropion Hcl	48	13
Pravastatin Sodium	Pravastatin Sodium	48	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	46	23
Montelukast Sodium	Montelukast Sodium	45	14
Ezetimibe	Ezetimibe	44	14
Mirtazapine	Mirtazapine	44	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	43	37
Symbicort	Budesonide/Formoterol Fumarate	43	suppressed
Gemfibrozil	Gemfibrozil	42	13
Buspirone Hcl	Buspirone Hcl	41	16
Citalopram Hbr	Citalopram Hydrobromide	40	11
Spironolactone	Spironolactone	40	14
Diazepam	Diazepam	38	suppressed
Azithromycin	Azithromycin	37	31
Metformin Hcl Er	Metformin Hcl	37	11
Lantus	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Chlorthalidone	Chlorthalidone	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Ibuprofen	Ibuprofen	33	14
Irbesartan	Irbesartan	33	suppressed
Amiodarone Hcl	Amiodarone Hcl	32	suppressed
Baclofen	Baclofen	32	suppressed
Memantine Hcl	Memantine Hcl	32	suppressed
Novolog Flexpen	Insulin Aspart	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Enalapril Maleate	Enalapril Maleate	30	suppressed
Telmisartan	Telmisartan	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Methotrexate	Methotrexate Sodium	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	15
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Sucralfate	Sucralfate	27	11
Atenolol	Atenolol	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	12
Glipizide	Glipizide	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Cephalexin	Cephalexin	23	18
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Amoxicillin	Amoxicillin	22	16
Folic Acid	Folic Acid	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Methimazole	Methimazole	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Valsartan	Valsartan	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	17
Benazepril Hcl	Benazepril Hcl	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Colchicine	Colchicine	14	suppressed
Ibu	Ibuprofen	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Lactulose	Lactulose	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Torsemide	Torsemide	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Niacin Er	Niacin	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Digoxin	Digoxin	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error